Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)

Clinical trial NCT00620659 · TERMINATED

Trial details

NCT number: NCT00620659
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Apnea, Obstructive Hypopnea Syndrome Excessive Daytime Sleepiness

Start date: 2008-02-01
Primary completion: 2009-02-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.